スロバキア -
スロバキア語 -
Adama
dirigent
adama - ec - difenoconazole 100 g/l + tebuconazole 250 g/l - fungicíd
スロバキア -
スロバキア語 -
Adama
artemis
adama - ec - fenpropidin 150 g/l + tebuconazole 100 g/l + prochloraz 200 g/l - fungicíd
欧州連合 -
スロバキア語 -
EMA (European Medicines Agency)
sialanar
proveca pharma limited - glycopyrronium bromid - sialorrhea - liečivá na funkčné gastrointestinálne poruchy - symptomatická liečba závažnej sialorrhoe (chronické ochorenie srdca) u detí a dospievajúcich vo veku 3 rokov a starších s chronickými neurologickými poruchami.
スロバキア -
スロバキア語 -
myHealthbox
adengo sc
bayer ag - tekutý dispergovateľný koncentrát - thiencarbazone-methyl 90 g/l; isoxaflutole 225 g/l; safener - cyprosulfamide 150 g/l
スロバキア -
スロバキア語 -
myHealthbox
adengo sc
bayer ag - tekutý dispergovateľný koncentrát - thiencarbazone-methyl 90 g/l; isoxaflutole 225 g/l; safener - cyprosulfamide 150 g/l
欧州連合 -
スロバキア語 -
EMA (European Medicines Agency)
budesonide/formoterol teva pharma b.v.
teva pharma b.v. - budesonide, formoterol - astma - drogy obštrukčnej choroby dýchacích ciest, - budesonid / formoterol teva pharma b. je indikovaná len u dospelých vo veku 18 rokov a starších. asthmabudesonide/formoterol teva pharma b. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: orin patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists. in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.
欧州連合 -
スロバキア語 -
EMA (European Medicines Agency)
innovax-nd-ilt
intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - imunologická liečba - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.